Table 2.
Compounds | Target | Effect on CMA | Refs |
---|---|---|---|
Cycloheximide | Protein synthesis inhibitor | Inhibition | [99] |
Anisomycin | Protein synthesis inhibitor | Inhibition | [99] |
SB230580 | P38 MAPK inhibitor | Inhibition | [99] |
Geldanamycin | HSP90 inhibitor | Activation | [99] |
17-AAG/DCA | HSP90 inhibitor + PDK1 inhibitor | Activation | [100] |
6-aminonicotinamide | G6PDH inhibitor | Activation | [99] |
synthetic ATRA derivatives | RAR-alpha inhibitor | Activation | [101] |
torin | TORC2 inhibitor | Activation | [24] |
TAK165/AC220 | MA inhibitor + FLT3 Inhibitor | Activation | [91] |
Spautin/AC220 | MA inhibitor + FLT3 Inhibitor | Activation | [32] |